Evidence map›Paper›PMID 30462538›Full record

ArticleAmerican journal of physiology. Cell physiology2019

The role of coagulation and platelets in colon cancer-associated thrombosis.

Annachiara Mitrugno, Samuel Tassi Yunga, Joanna L Sylman, Jevgenia Zilberman-Rudenko, Toshiaki Shirai, Jessica F Hebert, Robert Kayton, Ying Zhang, Xiaolin Nan, Joseph J Shatzel and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Review
  3. Hemostasis at the edge between physiology and cancer.Internal and emergency medicine · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Annachiara MitrugnoDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Samuel Tassi YungaDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Joanna L SylmanDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Jevgenia Zilberman-RudenkoDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Toshiaki ShiraiDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Jessica F HebertDepartment of Pathology, Oregon Health & Science University , Portland, Oregon.
Robert KaytonDepartment of Pathology, Oregon Health & Science University , Portland, Oregon.
Ying ZhangDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Xiaolin NanDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Joseph J ShatzelDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Sadik EsenerDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Matthew T DuvernayDepartment of Pharmacology, Vanderbilt University School of Medicine , Nashville, Tennessee.
Heidi E HammDepartment of Pharmacology, Vanderbilt University School of Medicine , Nashville, Tennessee.
András GruberDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Craig D WilliamsSchool of Pharmacy, Oregon State University , Portland, Oregon.
Yumie TakataCollege of Public Health & Human Science, Oregon State University , Corvallis, Oregon.
Randall ArmstrongKnight Cancer Institute, Oregon Health & Science University , Portland, Oregon.
Terry K MorganDepartment of Pathology, Oregon Health & Science University , Portland, Oregon.
Owen J T McCartyDepartment of Biomedical Engineering, School of Medicine, Oregon Health & Science University , Portland, Oregon.
Oregon Health & Science University · USOregon State University · USVanderbilt University · USVA Palo Alto Health Care System · US

Funding

Characterization of Coagulation Factor-platelet Interactions: Role of FXIR01HL101972 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Owen J McCarty · 2010 to 2026
$8.5M
Targeting PAR4 in Thrombotic Disorders:Pharmacogenomic ApproachR01HL133923 · NHLBI · VANDERBILT UNIVERSITY · PI HAMM, HEIDI E · 2017 to 2020
$2.3M
FXI and SepsisR01GM116184 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LUPU, FLOREA, MCCARTY, OWEN J · 2015 to 2018
$1.9M
Role of FXI in Thrombohemorrhagic ComplicationsF31HL136230 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ZILBERMAN-RUDENKO, JEVGENIA · 2017 to 2020
$161k
High Resolution Flow Cytometry Profiling of Extracellular Vesicles in PreeclampsiaR03HD096173 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MORGAN, TERRY KNUD, MYATT, LESLIE · 2018 to 2019
$154k
NHLBI NIH HHS F31 HL136230NHLBI NIH HHS R01 HL101972NHLBI NIH HHS R01 HL133923NICHD NIH HHS R03 HD096173NIGMS NIH HHS R01 GM116184
6 · The paper itself

Abstract

Cancer-associated thrombosis is a common first presenting sign of malignancy and is currently the second leading cause of death in cancer patients after their malignancy. However, the molecular mechanisms underlying cancer-associated thrombosis remain undefined. In this study, we aimed to develop a better understanding of how cancer cells affect the coagulation cascade and platelet activation to induce a prothrombotic phenotype. Our results show that colon cancer cells trigger platelet activation in a manner dependent on cancer cell tissue factor (TF) expression, thrombin generation, activation of the protease-activated receptor 4 (PAR4) on platelets and consequent release of ADP and thromboxane A2. Platelet-colon cancer cell interactions potentiated the release of platelet-derived extracellular vesicles (EVs) rather than cancer cell-derived EVs. Our data show that single colon cancer cells were capable of recruiting and activating platelets and generating fibrin in plasma under shear flow. Finally, in a retrospective analysis of colon cancer patients, we found that the number of venous thromboembolism events was 4.5 times higher in colon cancer patients than in a control population. In conclusion, our data suggest that platelet-cancer cell interactions and perhaps platelet procoagulant EVs may contribute to the prothrombotic phenotype of colon cancer patients. Our work may provide rationale for targeting platelet-cancer cell interactions with PAR4 antagonists together with aspirin and/or ADP receptor antagonists as a potential intervention to limit cancer-associated thrombosis, balancing safety with efficacy.

Indexed as

Blood CoagulationBlood PlateletsCell Line, TumorColonic NeoplasmsCross-Sectional StudiesHumansRetrospective StudiesThrombosisaspirincancercoagulationPAR4plateletsthrombosis

Identifiers

PMID30462538
PMCPMC6397342
OpenAlexW2901577023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.